GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Qol Holdings Co Ltd (TSE:3034) » Definitions » Forward PE Ratio

Qol Holdings Co (TSE:3034) Forward PE Ratio : 0.00 (As of Jun. 06, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Qol Holdings Co Forward PE Ratio?

Qol Holdings Co's Forward PE Ratio for today is 0.00.

Qol Holdings Co's PE Ratio without NRI for today is 10.16.

Qol Holdings Co's PE Ratio for today is 10.56.


Qol Holdings Co Forward PE Ratio Historical Data

The historical data trend for Qol Holdings Co's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qol Holdings Co Forward PE Ratio Chart

Qol Holdings Co Annual Data
Trend
Forward PE Ratio

Qol Holdings Co Quarterly Data
Forward PE Ratio

Competitive Comparison of Qol Holdings Co's Forward PE Ratio

For the Pharmaceutical Retailers subindustry, Qol Holdings Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qol Holdings Co's Forward PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Qol Holdings Co's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Qol Holdings Co's Forward PE Ratio falls into.



Qol Holdings Co Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Qol Holdings Co  (TSE:3034) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Qol Holdings Co Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Qol Holdings Co's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Qol Holdings Co (TSE:3034) Business Description

Traded in Other Exchanges
N/A
Address
4-3-1, Toranomon, 37th Floor, Shiroyama Trust Tower, Minato-ku, Tokyo, JPN, 105-8452
Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.

Qol Holdings Co (TSE:3034) Headlines

No Headlines